UnknownPhase 4

Vitamin D Supplementation in Pediatrics. Oral or Parenteral! D2 or D3

120 participantsStarted 2023-12

Plain-language summary

A study will be performed on Vitamin D deficient/ insufficient Egyptian children to compare the efficacy of oral and parenteral forms of Ergocalciferol and cholecalciferol in raising serum 25(OH) D levels in these subjects

Who can participate

Age range5 Years – 10 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * laboratory evidence of vitamin D deficiency or insufficiency without clinical signs of rickets Exclusion Criteria: * vitamin D or calcium supplementation within the last 6 months before inclusion, patients with diabetes mellitus, chronic liver disease and kidney disease, congenital or rheumatic heart disease, malabsorption syndromes, thyroid disease, juvenile rheumatic diseases, or other bone disorders.

What they're measuring

serum 25(OH) D level after 1,2,3 months of supplementation

Timeframe: 3 months

Trial details

NCT IDNCT06176157

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03

Contact for this trial

Marwa M Nawar, Lecturer

+201005368647 marwa_magdy@med.asu.edu.eg

View on ClinicalTrials.gov More Vitamin D Deficiency trials